Target intelligence / Profile preview

Dopamine D1, D2, D4 receptors (D1R, D2R, D4R)

Target
D1R, D2R, D4R
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Dopamine receptors D1, D2, and D4 are integral membrane proteins belonging to the G protein-coupled receptor superfamily. They are responsible for mediating the actions of dopamine within the central nervous system and the periphery, participating in the regulation of movement, motivation, reward, cognition, endocrine signaling, and metabolic processes. These receptors are divided into two major subclasses: D1-like (includes D1) and D2-like (includes D2 and D4), each coupled to specific intracellular signaling pathways with distinct physiological roles. Therapeutically, they are major targets for drugs in treatment of schizophrenia, Parkinson's disease, and other neuropsychiatric conditions. If you require structured information on a specific dopamine receptor (D1, D2, or D4), it is recommended to query each individually to obtain the most precise details for each subtype.

Other names
D1 dopamine receptorD2 dopamine receptorD4 dopamine receptorD1R, D2R, D4R
02

Mechanism of action

Antagonists: block receptor-mediated signaling, reducing dopamine activity; Agonists: activate the receptor, increasing dopamine signaling; Partial agonists: modulate signaling depending on dopamine concentration; Ligands target specific subtypes for selective pharmacological effects

03

Biological functions

Signal transductionModulation of neurotransmissionRegulation of motor controlCognitionMotivationRewardHormone secretionLipid and glucose metabolism (in adipose tissue)
04

Disease associations

Neuropsychiatric disorders (schizophrenia, depression, bipolar disorder)Parkinson’s diseaseAttention deficit hyperactivity disorder (ADHD)AddictionOther movement disorders
05

Safety considerations

Extrapyramidal symptoms (motor side effects, especially with D2 antagonism)Metabolic effects (weight gain, diabetes risk)Cardiac side effects (QT interval prolongation)Psychiatric symptoms (agitation, tardive dyskinesia)
06

Interacting drugs

Antipsychotics (e.g., clozapine, haloperidol)

3 more in the full profile.

07

Biomarkers

Genetic variants (e.g., DRD4 VNTR polymorphism in D4 receptor)Receptor density and distribution via PET imaging

Beyond the preview

Go deeper on Dopamine D1, D2, D4 receptors (D1R, D2R, D4R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dopamine D1, D2, D4 receptors (D1R, D2R, D4R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call